← Back to BBNX

Beta Bionics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 29/07/2026Mar 2026Filed 21/04/2026Sep 2025Filed 28/10/2025Jun 2025Filed 29/07/2026Mar 2025Filed 21/04/2026Sep 2024Filed 28/10/2025Jun 2024Filed 29/07/2025Mar 2024Filed 06/05/2025
$32$28$27$23$18$17$15$13
−$23−$22−$14−$17−$29−$9.7−$14−$12
−$0.53−$0.49−$0.33−$0.39−$0.93−$1.46−$2.37−$2.07
45444443316.76.16

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.